Skip to main content
Search form
Search
Medicines for Malaria Venture
Developing antimalarials to save lives
Research & Development
MMV-supported projects
R&D areas of work
Next-generation medicines
Products for key populations
Working with regulators
Information for scientists
Malaria online course
Global health compound design webinars
Call for proposals
TPPs & TCPs
Learning resources for scientists
Project of the year award
Computational chemistry
R&D challenges
Access
Products & projects
Product availability maps
Areas of work
Supporting introduction
Enhancing reach
Informing R&D
Gathering market intelligence
Tool Kits
Injectable Artesunate tool kit
Artesunate rectal capsules tool kit
Seasonal Malaria Chemoprevention tool kit
Access challenges
Partnering
The PDP model
Our partner network
Our donors
Current donors
Past donors
Donate to MMV
Socially responsible agreements
Our clinical centre partners
Our impact
Milestones
Real life stories
Better medicines for children
Gender equity
Global health security
Malaria and COVID-19
Tackling antimicrobial resistance
About us
What we do
An overview of our work
Our strategic focus
Our history
People & governance
Staff bios
Staff interviews
Board of Directors
MMV North America Board
Expert Scientific Advisory Committee
Access & Product Management Advisory Committee
Global Safety Board
Work with us
Jobs
RFPs/RFIs
Policies
Diversity at MMV
Funding and expenditure
FAQs
Contact us
Malaria & medicines
Definitions and symptoms
Five species
Parasite lifecycle
Malaria facts & figures
Malaria treatment
History of antimalarials
Newsroom
News & Press Releases
Audio
Media interviews
Speaking of Malaria podcast
Films
Infographics
Interviews
Image slideshows
Publications
Events
MMV Open
Malaria
Libre
About Malaria
Libre
Participate in Malaria
Libre
Malaria
Libre
data repository
MMVSola
About MMVSola
Pandemic Response Box
About the Pandemic Response Box
Request the Pandemic Response Box
Supporting information
Terms & conditions
COVID Box
About the COVID Box
Supporting information
COVID Box terms and conditions
Archived projects
Pathogen Box
Malaria Box
MMV Open Team
Contact us
Home
Newsroom
News & Press Releases
News & Press Releases
Filter
Category
All
News story
Press release
Topic
Access & product management
Donors
General
Open source
Partner
R&D
Search Terms
456 found
This World Malaria Day MMV joins Swiss Malaria Group in calling for increased commitment to combatting malaria
22 Apr 2022
MMV welcomes Alan Court as new Board Chair
12 Apr 2022
Dr Pedro Alonso retires from position as Director of WHO’s Global Malaria Programme
01 Apr 2022
Global Health 50/50 launches report
Boards for all?
30 Mar 2022
Single-dose Kozenis (tafenoquine) approved for children with
Plasmodium vivax
malaria by Australian Therapeutic Goods Administration
14 Mar 2022
Professor Michael Ferguson receives British Society for Parasitology Honorary Membership
04 Mar 2022
Ongoing challenges and renewed commitment: MMV’s progress in 2021
14 Dec 2021
MMV supports open letter urging decision makers to scale-up access to preventive malaria treatment in pregnancy
10 Dec 2021
Malaria kills more children than previously estimated according to World Malaria Report
06 Dec 2021
MMV deeply saddened by the loss of Dr Martin de Smet
01 Dec 2021
MMV launches innovative drug research tool
01 Dec 2021
Dr Elizabeth Winzeler elected to the National Academy of Medicine
21 Oct 2021
First real-world use of new protocol for
P. vivax
case management in Brazil – a Health Ministry and MMV collaboration
07 Oct 2021
First-ever malaria vaccine to get WHO recommendation for roll-out
07 Oct 2021
Novartis and Medicines for Malaria Venture report positive results for Phase IIb study of novel ganaplacide/lumefantrine combination in children with malaria
29 Sep 2021
MMV mourns the loss of Dr Tachi Yamada
15 Aug 2021
New partnership launched to accelerate elimination of relapsing
P. vivax
malaria that poses a risk to an estimated 2.5 billion people worldwide
14 Jul 2021
Pyronaridine-artesunate demonstrates high real-life safety, tolerability and effectiveness in the treatment of uncomplicated malaria in large multi-country study in Africa
17 Jun 2021
MMV devises a predictive tool to assess resistance to antimalarial compounds and guide their development
31 May 2021
MMV and DND
i
urge WHO member states to invest in medicines for women and children
27 May 2021
MMV and partners recognize malaria innovations and urge WHO member states to scale up investments
26 May 2021
MMV recognizes partner Novartis’ milestone of 1 billion courses of antimalarial delivered
18 May 2021
MMV deeply saddened by the loss of Ambassador Dr Konji Sebati
18 May 2021
SMC scale-up significantly reduces child mortality in the Sahel
10 May 2021
MMV’s partner S Kant receives WHO prequalification for its protective medicine for children
23 Apr 2021
This World Malaria Day MMV recognizes Swiss Malaria Group's commitment to defeating malaria
19 Apr 2021
MMV mourns the loss of Professor Sir Colin Dollery
29 Jan 2021
New report demonstrates how R&D partnerships serving neglected communities have developed dozens of life-saving innovations since 2010
28 Jan 2021
Republic of Korea grants USD 10 million to MMV-led consortium to protect children from malaria in the Sahel
28 Jan 2021
GSK, MMV filing for Kozenis (tafenoquine) in paediatric populations with
Plasmodium vivax
malaria accepted by Australian Therapeutic Goods Administration
08 Jan 2021
Looking Back at An Extraordinary Year
18 Dec 2020
MMV awards Project of the Year 2020 to Professor David Fidock and team for critical contribution to malaria drug resistance profiling
18 Dec 2020
MMV’s Adam Aspinall appointed as Chair of the new Fight the Fakes Alliance
14 Dec 2020
MMV supports the launch of the new Fight the Fakes Alliance
07 Dec 2020
World Malaria Report highlights two decades of progress while calling for increased commitment as gains plateau
30 Nov 2020
Largest clinical trial in Africa to treat COVID-19 cases before they become severe
20 Nov 2020
GSK and MMV present positive data on treatment of
Plasmodium vivax
malaria
19 Nov 2020
Endemic countries in South America meet to discuss new tools for malaria elimination
02 Nov 2020
Global call to boost access to lifesaving malaria treatment for pregnant women in Africa
15 Oct 2020
Despite early indicators of artemisinin resistance in Rwanda, ACTs continue to cure malaria
19 Aug 2020
MMV awards Project of the Year 2019 to Novartis for the discovery of INE963
13 Jul 2020
MMV launches Malaria
Libre
, a new open source drug discovery programme
07 Jul 2020
ESAC member Sir Simon Campbell inducted into the RSC-BMCS Hall of Fame
30 Jun 2020
MMV deeply saddened by the loss of Dr Ricardo Thompson
26 Jun 2020
MMV’s Dr James Duffy appointed to RSC Lectureship
19 Jun 2020
MMV launches the COVID Box to stimulate new drug research
10 Jun 2020
MMV submits statement to 73rd World Health Assembly
19 May 2020
This World Malaria Day MMV supports Swiss Malaria Group's call for urgent action
25 Apr 2020
Thailand becomes first malaria-endemic country in Asia-Pacific to approve tafenoquine for radical cure of
P. vivax
malaria
24 Apr 2020
In support of the COVID-19 response
31 Mar 2020
MMV and LSTM collaborate to fill data gap on use of antimalarials during pregnancy
08 Mar 2020
International research partnership and EDCTP to invest €44m in next-generation antimalarials to combat drug-resistant malaria in Africa
03 Mar 2020
Malaria continues to strike pregnant women and children hardest and new tools are critical, according to WHO’s latest report
05 Dec 2019
Research for new drugs against neglected diseases and malaria in Brazil to receive funding boost totaling BRL 43.5 million
27 Nov 2019
MMV presents Lifetime Achievement Awards to three longstanding collaborators
25 Nov 2019
Country leaders pledge to boost malaria innovation and access to new and existing antimalarials
11 Nov 2019
Brazil becomes first malaria-endemic country to approve single-dose tafenoquine (Kozenis) for radical cure of
P. vivax
malaria
30 Oct 2019
MMV and PATH strengthen ties with APLMA in the fight against relapsing malaria
22 Oct 2019
WHO issues information note about Pyramax® (artesunate-pyronaridine) for uncomplicated malaria
09 Oct 2019
MMV contributes to the fight against schistosomiasis
30 Sep 2019
Pages
1
2
3
4
5
6
7
8
next ›
last »